Susan Lisa | Vice President, Investor Relations |
Michael Mahoney | Chairman and Chief Executive Officer |
Daniel Brennan | Executive Vice President and Chief Financial Officer |
Ian Meredith | Executive Vice President and Global Chief Medical Officer |
Kenneth Stein, MD | SVP & Chief Medical Officer, Rhythm Management & Global Health Policy |
David Lewis | Morgan Stanley |
Glenn Novarro | RBC Capital Markets |
Bob Hopkins | Bank of America |
Larry Biegelsen | Wells Fargo |
Chris Pasquale | Guggenheim |
Rick Wise | Stifel |
Vijay Kumar | Evercore ISI |
Josh Jennings | Cowen |
Matt Taylor | UBS |
Joanne Wuensch | BMO |
Matt Miksic | Credit Suisse |
Isaac Ro | Goldman Sachs |
Ladies and gentlemen, thank you for standing by. Welcome to the Boston Scientific Fourth Quarter 2018 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session, instructions will be given at that time. [Operator Instructions] As a reminder, this conference is being recorded.